- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical evaluation of therapeutic cancer vaccines
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 9, Issue 5, Pages 1049-1057
Publisher
Informa UK Limited
Online
2013-03-18
DOI
10.4161/hv.23917
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The immune score as a new possible approach for the classification of cancer
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- Clinical Evaluation of TRICOM Vector Therapeutic Cancer Vaccines
- (2012) Ravi A. Madan et al. SEMINARS IN ONCOLOGY
- Active-specific immunotherapy of human cancers with the heat shock protein Gp96-revisited
- (2011) Marco Randazzo et al. INTERNATIONAL JOURNAL OF CANCER
- Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma
- (2011) Stephen J. Schuster et al. JOURNAL OF CLINICAL ONCOLOGY
- A methodological framework to enhance the clinical success of cancer immunotherapy
- (2011) Axel Hoos et al. NATURE BIOTECHNOLOGY
- Therapeutic cancer vaccines: Why so few randomised phase III studies reflect the initial optimism of phase II studies
- (2011) Angus G. Dalgleish VACCINE
- NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines
- (2010) Luis E. Fernandez et al. Clinical & Developmental Immunology
- Strategies for Cancer Vaccine Development
- (2010) Matteo Vergati et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- A Phase 2 Trial of Immunotherapy With Mitumprotimut-T (Id-KLH) and GM-CSF Following Rituximab in Follicular B-cell Lymphoma
- (2010) Omer N. Koç et al. JOURNAL OF IMMUNOTHERAPY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
- (2009) Celestia S. Higano et al. CANCER
- Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy With Mitumprotimut-T and Granulocyte-Macrophage Colony-Stimulating Factor After Rituximab in Patients With Follicular Lymphoma
- (2009) Arnold Freedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma
- (2009) John M. Timmerman et al. LEUKEMIA & LYMPHOMA
- Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings
- (2008) E Jonasch et al. BRITISH JOURNAL OF CANCER
- Allovectin-7 therapy in metastatic melanoma
- (2008) Agop Y Bedikian et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group
- (2008) Alessandro Testori et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation